Evidence map›Paper›PMID 33972781›Full record

ArticleNature genetics2021

Long-read sequencing of 3,622 Icelanders provides insight into the role of structural variants in human diseases and other traits.

Doruk Beyter, Helga Ingimundardottir, Asmundur Oddsson, Hannes P Eggertsson, Eythor Bjornsson, Hakon Jonsson, Bjarni A Atlason, Snaedis Kristmundsdottir, Svenja Mehringer, Marteinn T Hardarson and 22 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 197 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
197citing papers in PubMed, 1 pooled it
40.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

197 citing papers in PubMed, 1 synthesis or guideline pooled it, 279 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Structural Variant Imputation in Samoans Using a Population-Specific Reference Panel.medRxiv : the preprint server for health sciences · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

137 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 6 institutions in 2 countries.

Doruk BeyterdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-3644-5760
Helga IngimundardottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-2780-3546
Asmundur OddssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-4606-5163
Hannes P EggertssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-1674-9978
Eythor BjornssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Hakon JonssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-6197-494X
Bjarni A AtlasondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Snaedis KristmundsdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Svenja MehringerAlgorithmic Bioinformatics (ABI), Freie Universitat Berlin, Berlin, Germany.
Marteinn T HardarsondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Sigurjon A GudjonssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Droplaug N MagnusdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Aslaug JonasdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Adalbjorg JonasdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Ragnar P KristjanssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-3678-5693
Sverrir T SverrissondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Guillaume HolleydeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Gunnar PalssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-8231-3961
Olafur A StefanssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Gudmundur EyjolfssonThe Laboratory in Mjodd, Reykjavik, Iceland.
Isleifur OlafssonDepartment of Clinical Biochemistry, Landspitali-the National University Hospital of Iceland, Reykjavik, Iceland.
Olof SigurdardottirDepartment of Clinical Biochemistry, Akureyri Hospital, Akureyri, Iceland.
Bjarni TorfasonFaculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Gisli MassondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Agnar HelgasondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-8545-3767
Unnur ThorsteinsdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Hilma HolmdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-9517-6636
Daniel F GudbjartssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-5222-9857
Patrick SulemdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-7123-6123
Olafur T MagnussondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Bjarni V HalldorssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland. bjarnih@decode.is.ORCID http://orcid.org/0000-0003-0756-0767
Kari StefanssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland. kstefans@decode.is.ORCID http://orcid.org/0000-0003-1676-864X
deCODE Genetics (Iceland) · ISReykjavík University · ISAkureyri Hospital · ISFreie Universität Berlin · DENational University Hospital of Iceland · ISUniversity of Iceland · IS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-read sequencing (LRS) promises to improve the characterization of structural variants (SVs). We generated LRS data from 3,622 Icelanders and identified a median of 22,636 SVs per individual (a median of 13,353 insertions and 9,474 deletions). We discovered a set of 133,886 reliably genotyped SV alleles and imputed them into 166,281 individuals to explore their effects on diseases and other traits. We discovered an association of a rare deletion in PCSK9 with lower low-density lipoprotein (LDL) cholesterol levels, compared to the population average. We also discovered an association of a multiallelic SV in ACAN with height; we found 11 alleles that differed in the number of a 57-bp-motif repeat and observed a linear relationship between the number of repeats carried and height. These results show that SVs can be accurately characterized at the population scale using LRS data in a genome-wide non-targeted approach and demonstrate how SVs impact phenotypes.

Indexed as

Genomic Structural VariationHigh-Throughput Nucleotide SequencingQuantitative Trait, HeritableAllelesCholesterol, LDLChromosomes, HumanDiseaseFemaleGene FrequencyHumansIcelandLinear ModelsMaleProprotein Convertase 9Recombination, GeneticSequence DeletionCholesterol, LDLProprotein Convertase 9

Identifiers

PMID33972781
OpenAlexW3162917414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.